Amneal Pharmaceuticals's total assets for Q1 2025 were $3.37B, a decrease of -3.89% from the previous quarter. AMRX total liabilities were $2.35B for the fiscal quarter, a -34.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.